HIS 125 Ototoxic Medications Overview
-
Upload
rebecca-waldo -
Category
Documents
-
view
527 -
download
0
Transcript of HIS 125 Ototoxic Medications Overview
![Page 1: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/1.jpg)
Various drugs used for therapeutic treatment have the potential side effects of causing damage to the inner ear structures.
![Page 2: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/2.jpg)
If the damage progresses, functional hearing impairment and/or balance, with tinnitus is a common complaint.
The revealed impairment can be either permanent or temporary and either unilateral of bilateral in nature.
![Page 3: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/3.jpg)
The severity of a patient’s health condition may override the concern for ototoxic side effects in medical management. However, one should always be aware of the “quality of life”, and the importance of maintaining functional hearing cannot be overemphasized.
![Page 4: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/4.jpg)
Almost every major category of medications contains drugs that can be ototoxic.
Substances of abuse/excess such as alcohol, marijuana, and tobacco can be toxic to the auditory system.
Heavy metals and chemical solvents can also be ototoxic.
![Page 5: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/5.jpg)
Aminoglycoside Antibiotics
All aminoglycosides are ototoxic to some degree. Streptomycin, first used in the successful treatment of tuberculosis, was also found to be quite ototoxic.
![Page 6: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/6.jpg)
Aminoglycoside Antibiotics
Others found to be ototoxic include:
1. Gentamicin
2. Tobramycin
3. Amikacin
4. Netilmicin
5. Kanamycin
6. Neomycin
![Page 7: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/7.jpg)
Aminoglycoside Antibiotics
Streptomycin and Gentamicin are often used to ablate inner ear structures for the relief of Meniere's syndrome symptoms.
![Page 8: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/8.jpg)
Aminoglycoside Antibiotics
Netilmicin and neomycin may be the least ototoxic.
![Page 9: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/9.jpg)
Aminoglycoside Antibiotics
Damage caused by them begins at the basal end of the cochlea and progresses toward the apex.
The concentration of them will remain high within the perilymph fluid, long after the concentration within the blood has diminished.
![Page 10: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/10.jpg)
Cancer Chemotherapeutics
There are significant potentials for ototoxicity among these drugs. They include:
1. Cisplatin
2. Carboplatin
3. Nitrogen mustard
4. Alpha-Difluoromethylornithine (DFMO)
![Page 11: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/11.jpg)
Cancer Chemotherapeutics
Cisplatin may be the most ototoxic of all.
Its effects also reveal cochlear damage beginning at the basal end (high frequency).
Carboplatin is a second generation of Cisplatin and was designed to create less side-effects however, ototoxicity has been reported with its use.
![Page 12: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/12.jpg)
Cancer Chemotherapeutics
Chemoprotective agents have been designed to reduce the side-effects of anti-tumor drugs. Research into these medications involves audiologists who use standardized measures to monitor success or failure.
![Page 13: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/13.jpg)
Loop Diuretics
The most common ones of concern are: furosemide and ethacrynic acid.
![Page 14: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/14.jpg)
Loop Diuretics
By themselves, they usually only create a temporary threshold shift; however, when used with aminoglycosides permanent cochlear damage may result.
![Page 15: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/15.jpg)
Other commonly used medications which generally result in temporary hearing loss are:
Salicylates (aspirin is most common)
Propionic acid (ibuprofen is most common)
Quinine (irreversible HL may result when high dosages are used)
![Page 16: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/16.jpg)
There are several factors which exacerbate or increase the hearing loss effects of ototoxic drugs. Such as:
Excessive noise exposure
Drug interactions
Opportunistic /physiologic susceptibility
Pre-existing hearing loss or vestibular disorder.
![Page 17: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/17.jpg)
Audiometry & Ototoxicity monitoring
Most ototoxic drugs compromise the basal end (high frequency) area of the cochlea.
A high frequency baseline audiogram is recommended before beginning the use of these ototoxic drugs.
![Page 18: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/18.jpg)
Audiometry & Ototoxic monitoring
This monitoring generally involves frequencies above 4K, using high frequency audiometers.
![Page 19: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/19.jpg)
Audiometry & Ototoxic monitoring
Ideally, the highest five frequencies which the patient responds, are used as the baseline for future hearing level measurements.
For example: 6K, 8K, 12K, 14K, 16K.
![Page 20: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/20.jpg)
Audiometry & Ototoxic monitoring
When the threshold at any frequency shifts by more than ten decibels, ototoxic effects may be present. When adjacent frequencies are involved, most certainly effects have occurred.
When a twenty decibel shift occurs at any single frequency, ototoxicity effects are present.
![Page 21: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/21.jpg)
Audiometry & Ototoxic monitoring
For Aminoglycoside treated patients, audiometric testing should be done every two to four days during treatment.
For Cisplatin patients, audiometric testing should be done within twenty-four hours of each treatment.
![Page 22: HIS 125 Ototoxic Medications Overview](https://reader033.fdocuments.in/reader033/viewer/2022051400/55987c031a28ab63638b45be/html5/thumbnails/22.jpg)
Audiometry & Ototoxic monitoring
Follow-up audiometric testing should be scheduled up to thirty days after Ototoxic treatments have been discontinued.
Audiometric monitoring can be very useful in the successful treatment and best practices outcomes for patient healthcare.